Big Ass Bag
Pre Seed Round in 2023
Big Ass Bag (BAB) is a digital platform that streamlines online shopping by offering a universal shopping cart. Users can add items from various stores and categories, including electronics, fashion, groceries, and more, all in one place. BAB enables users to compare products, create and share wishlists, and save selections for future purchases, enhancing the convenience of online shopping.
PrivacyBrain
Seed Round in 2021
PrivacyBrain operates a cybersecurity platform that automatically identifies and removes exposed personal information of employees from data broker sites across the internet. Their intuitive dashboard enables businesses to monitor what sensitive data has been exposed and track its removal progress. Post-removal, PrivacyBrain continues to scan for newly exposed information and automates further removal requests, helping clients mitigate risks associated with cyber-attacks and phishing campaigns stemming from publicly available employee personal identifying information (PII).
THG Energy Solutions
Seed Round in 2019
THG Energy Solutions, LLC is a provider of energy management solutions aimed at diverse sectors such as governments, healthcare, education, and retail. Founded in 2003 and headquartered in Austin, Texas, with additional offices in Tulsa and Atlanta, the company specializes in a web-based platform that facilitates utility data management and reporting. Its services include automated demand response, integrated load management, data collection and verification, and accounts payable integration. By leveraging actionable energy analytics and sustainability reporting, THG Energy Solutions helps clients achieve cost savings and resource conservation while mitigating risks. The company is committed to delivering tailored energy management strategies that align with the interests of its clients, supported by a team with expertise in energy marketing, engineering, and data management. THG Energy Solutions maintains a strategic alliance with Energy Hippo, Inc.
Simergent
Seed Round in 2019
Simergent, LLC is a manufacturer of automated peritoneal dialysis devices, established in 2014 and headquartered in Oklahoma City, Oklahoma, with an additional presence in Chicago, Illinois. The company focuses on developing affordable home dialysis solutions for both developed and emerging markets. Its innovative device is designed to be cost-effective and user-friendly, featuring a disposable tubing set that operates independently to troubleshoot issues. This enables patients to maintain a normal lifestyle and engage socially with family and friends while undergoing treatment at home, thereby enhancing their quality of life.
BPEndo
Venture Round in 2019
BPEndo, LLC is a medical device company based in Norman, Oklahoma, incorporated in 2016. The company specializes in developing an insufflation retention device designed to address the challenge of a deflating colon during colonoscopy procedures. This innovative device creates an airtight seal in the rectum, which helps prevent air or fluid incontinence. By maintaining proper insufflation, BPEndo's device enhances the safety and efficiency of colonoscopies, allowing physicians greater freedom of movement with the endoscope during examinations.
Progentec Diagnostics
Venture Round in 2018
Progentec Diagnostics, Inc. is a company focused on developing innovative diagnostic tests for managing systemic lupus erythematosus (SLE). Established in 2015 and headquartered in Oklahoma City, Oklahoma, the company has created the aiSLE DX platform, which offers tools like a flare prediction score to measure disease activity in SLE patients and an early diagnostic test for lupus. Progentec integrates advanced technology and collaborates with research institutions globally, aiming to address significant unmet needs in diagnostic interventions. The company's mission centers on improving disease management and reducing disease incidence through enhanced screening and early detection.
Whiteboard Mortgage CRM
Series A in 2018
Whiteboard Mortgage CRM is a specialized software company that provides customer relationship management tools tailored for mortgage professionals. Founded by leading figures in the mortgage industry, Whiteboard aims to enhance the efficiency of loan officers and branch managers by facilitating better client and referral partner relationships. The company's innovative software accelerates lead management, partner engagement, and team productivity, ultimately driving revenue growth for mortgage businesses. By enabling lenders to implement cohesive sales, marketing, and follow-up campaigns while ensuring compliance, Whiteboard's platform helps users close more loans and increase referrals. Its commitment to supporting mortgage professionals has earned it recognition as one of the most innovative companies in the sector.
SendaRide
Series A in 2018
SendaRide, Inc. is a transportation service provider focused on non-emergency medical transportation for patients, particularly the elderly and children. Founded in 2016 and headquartered in Oklahoma City, the company operates a platform that allows users to find and book both on-demand and pre-scheduled rides. SendaRide's application offers customized transportation solutions tailored to the healthcare industry, facilitating safe and reliable transport for users. Additionally, the platform includes features such as GPS monitoring and live video feeds, allowing users to track their drivers or caretakers during transit. Users can also rate their experiences, enhancing service accountability and quality.
Raw Space For Rent
Seed Round in 2018
Raw Space For Rent Inc. is a transactional platform founded in 2015 and based in Oklahoma City, Oklahoma, that connects individuals seeking to monetize their unused spaces with those in need of temporary rental options. The company operates an online community marketplace where users can list and discover various types of raw spaces for rent, accommodating a wide range of activities such as events, performances, storage, and creative projects. By facilitating peer-to-peer rentals, Raw Space For Rent enables users to turn their unused areas into income-generating opportunities while offering renters diverse options for their specific needs, whether for artistic endeavors, social gatherings, or practical purposes.
iRecommend Software™
Series A in 2017
iRecommend Software™ develops intelligent business solutions utilizing artificial intelligence (AI), machine learning, and dynamic data modeling. In a consumer-driven economy, businesses across all industries, are facing the challenge to remain relevant and provide highly personalized products and services. iRecommend's leading solution, Recommendation360™ is a recommendation engine with applications across multiple industries, including recruiting, real estate, retail/e-commerce, entertainment, travel, government, and healthcare. These industry-specific solutions enable businesses to generate hyper-personalized recommendations of products and services for their customers. Recommendation360's proprietary technology rapidly aggregates and analyzes millions of data points from the public domain to provide the right products or services to the right person at the right time. Headquartered in Tulsa, Oklahoma with offices in Oklahoma City, New York, San Francisco, London, and Dubai.
Clear River Enviro
Series A in 2017
Clear River Enviro, LLC is a company based in Sugar Land, Texas, that specializes in the manufacture and marketing of devices designed for the safe and convenient disposal of pharmaceutical waste in healthcare settings such as hospitals and nursing homes. Established in 2009, the company addresses the critical need for effective waste management in the medical sector, ensuring compliance with regulations and promoting environmental sustainability.
Linear Health Sciences
Series A in 2017
Linear Health Sciences is a medical device company focused on developing innovative products for medical tubing, utilizing its proprietary breakaway safety-valve technology. This technology aims to prevent unwanted disconnections during medical procedures, thereby enhancing the healthcare experience for patients, caregivers, and healthcare facilities. Founded by a physician and two engineers, the company has made significant strides in securing global patent protections and pursuing FDA clearance for its flagship product, the Orchid Safety Release Valve. With a total addressable market exceeding $1 billion annually, Linear Health Sciences is positioned to address critical needs in patient care and safety within the healthcare industry.
Progentec Diagnostics
Venture Round in 2017
Progentec Diagnostics, Inc. is a company focused on developing innovative diagnostic tests for managing systemic lupus erythematosus (SLE). Established in 2015 and headquartered in Oklahoma City, Oklahoma, the company has created the aiSLE DX platform, which offers tools like a flare prediction score to measure disease activity in SLE patients and an early diagnostic test for lupus. Progentec integrates advanced technology and collaborates with research institutions globally, aiming to address significant unmet needs in diagnostic interventions. The company's mission centers on improving disease management and reducing disease incidence through enhanced screening and early detection.
MaxQ LLC is a manufacturer of insulated shipping containers specifically designed for the life science industry, focusing on the safe transportation of temperature-sensitive goods such as blood, biologics, and pharmaceuticals. Founded in 2012 and based in Stillwater, Oklahoma, the company offers operationally validated cold chain packaging solutions that ensure effective thermal control during shipping. MaxQ specializes in providing optimized packaging solutions with validated shipping and storage systems, including pre-qualified pack-outs that can maintain product integrity for up to three days. The company also facilitates reusable and custom packaging options, significantly reducing the risk of product loss due to breakage or inadequate insulation in the healthcare sector.
Happily
Seed Round in 2017
Happily is a developer of a date-planning app designed to enhance the relationship experiences of couples. The app offers personalized date ideas and gifting suggestions, along with monthly subscription boxes that deliver curated activities directly to users. By focusing on unique and engaging experiences, Happily enables couples to rediscover the joy of date nights, fostering deeper connections and quality time together. The platform aims to make planning fun and meaningful, encouraging couples to explore new ways to bond and strengthen their relationships.
Happily
Seed Round in 2017
Happily is a developer of a date-planning app designed to enhance the relationship experiences of couples. The app offers personalized date ideas and gifting suggestions, along with monthly subscription boxes that deliver curated activities directly to users. By focusing on unique and engaging experiences, Happily enables couples to rediscover the joy of date nights, fostering deeper connections and quality time together. The platform aims to make planning fun and meaningful, encouraging couples to explore new ways to bond and strengthen their relationships.
Spiers New Technologies
Venture Round in 2016
Spiers New Technologies Inc. specializes in providing comprehensive repair, remanufacturing, refurbishing, and repurposing services for battery packs utilized in hybrid and electric vehicles. Established in 2014 and headquartered in Oklahoma City, Oklahoma, the company enables original equipment manufacturers to effectively manage the life cycle of their battery pack inventories. In addition to its core 4R services, Spiers New Technologies conducts qualitative analysis and safety assessments of removed battery packs and manages logistics, including climate-controlled storage and recycling preparation. The company also offers contract design and manufacturing services for energy storage systems applicable to various non-vehicle uses, such as stationary electricity storage, vehicle recharging stations, and solar support systems.
WeGoLook, LLC is a mobile technology company that provides on-demand inspection, verification, and field services through a crowdsourced platform of over 30,000 independent contractors, known as "Lookers." Headquartered in Oklahoma City, Oklahoma, WeGoLook serves both businesses and consumers in the United States and internationally, including markets such as the United Kingdom, Canada, and Australia. The company specializes in verifying various assets, including automobiles, motorcycles, RVs, and properties, and offers services such as accident scene inspections, document retrieval, indoor and outdoor asset verification, and custom tasking like item pickup and delivery. Clients engage with WeGoLook to obtain comprehensive inspection reports, which are compiled from field data, photos, and videos collected by Lookers using the WeGoLook mobile app. Following a quality assurance review, the reports are delivered to clients, including insurance providers, in various formats. WeGoLook aims to facilitate faster and more accurate verification processes for its clients while supporting a wide range of industries, from automotive to real estate and beyond. The company was founded in 2009 and operates as a subsidiary of Crawford & Company.
Synereca Pharmaceuticals
Venture Round in 2015
Synereca Pharmaceuticals, Inc. is a research-stage biopharmaceutical company focused on developing orally active drugs that enhance the effectiveness of existing antibiotics. Founded in 2009, the company is headquartered in Chapel Hill, North Carolina, with additional laboratories in Oklahoma. Synereca's research centers on compounds that increase the activity of Colistin against gram-negative bacteria while avoiding toxicity. Its portfolio includes prototypic RecA inhibitors aimed at treating various pathogenic bacteria, including E. coli, which are responsible for infections in the lungs, urinary tract, and skin, as well as other harmful pathogens. The company identifies multiple chemical subclasses of compounds that potentiate various classes of antibiotics, including polymyxins, carbapenems, aminoglycosides, and fluoroquinolones, thereby facilitating the development of more effective treatments for bacterial infections.
Exaptive
Seed Round in 2015
Exaptive, Inc. is a company that provides an application development platform tailored for data science, aimed at fostering innovation and collaboration among users. Founded in 2011 and headquartered in Oklahoma City, Oklahoma, Exaptive offers products such as the Xap Store, an app store for data applications, and Cognitive Network, a community that connects users through shared interests and expertise. The platform is designed to facilitate the organization of teams and interdisciplinary communities, enhancing productivity by enabling seamless collaboration on data analysis. By streamlining the interaction between data and intuition, Exaptive empowers users to generate new ideas and effectively tackle complex problems.
Moleculera Biosciences
Venture Round in 2015
Moleculera Labs was founded by Drs. Craig Shimasaki and Madeleine Cunningham in 2011, to medically understand and clinically identify the underlying biological root of neurological, psychiatric, and behavioral disorders. Similar to the emergence of the immuno-oncology connection, epidemiological and research evidence demonstrates that a large portion of neuropsychiatric disorders are caused by an autoimmune dysfunction. The Company owns and operates a fully accredited clinical laboratory with its first revenue generating product—a blood panel called the Cunningham Panel™ that detects brain and nervous system targeted autoimmune antibodies in patients with neurologic, psychiatric, and behavioral disorders triggered by an infection. Patients are diagnosed with PANS, PANDAS, autism spectrum disorder, ADD/ADHD, bipolar disorder, anxiety disorder, Tourette’s, obsessive compulsive disorder (OCD), schizophrenia, or other neurologic and psychiatric syndromes, whereas the root may be a dysfunctional immune response. Symptoms include OCD, anxiety, depression, psychosis, motor or vocal tics, verbal and non-verbal communication difficulty, deteriorating social skills, eating disorders, academic regression, and rage. These patients are typically prescribed neuropsychiatric drugs, often resulting in little or no improvement. However, once a patient is correctly diagnosed through testing, treatment is redirected towards the immune system, neuroinflammation, and subclinical infections, resulting in remarkable recoveries, sometimes after decades of suffering. Moleculera is the sole clinical laboratory performing this panel covered by two U.S. patents. The Company has received and processed over 13,000 blood specimens ordered by over 1,700 physicians in over 50 countries, all prior to launching a sales force. The Company generated $1.1 MM in 2021 and is preparing to scale for revenue expansion with expectations of revenue ~$25 MM in 4-5 years. The company is now applying this technology to autoimmune cardiovascular disease and Long-COVID symptoms. The basic research that led to the identification of these antineuronal antibody targets was studied for over 20 years in the laboratory of Dr. Madeleine Cunningham at The University of Oklahoma Health Sciences Center, with subsequent collaboration from the Pediatric Branch of the National Institutes of Mental Health (NIMH). Scientific and clinical results have been published in multiple top-tier peer-reviewed journals. Certain infections that have been found to trigger these autoimmune antibodies include strep, Lyme, mycoplasma, Babesia, bartonella, coxsackie virus, and others. Medical journals have reported an autoimmune response to SARS-CoV-2 (COVID-19), with approximately one-third of patients experiencing some neurologic or psychiatric symptoms. The patented Cunningham Panel™ consists of five tests. Four which measure levels of autoantibodies directed against Dopamine D1 receptor, Dopamine D2L receptor, Lysoganglioside GM1, and Tubulin. A fifth test measures CaM Kinase II activation, a key enzyme involved in the production of neurotransmitters dopamine, epinephrine, and norepinephrine. Autoimmune antibodies that bind to these targets interfere with or block normal neurologic activity in the brain and nervous system. The laboratory results assist a physician in making a diagnosis and identifying the appropriate therapy. In addition to individual clinicians who order the panel, the Company has provided testing to over 80 medical institution customers. In a 2020 publication in the Journal of Neuroimmunology, the Cunningham Panel demonstrated an 88% sensitivity and 92% specificity with an accuracy of 90% correlating these autoantibody elevations and neuropsychiatric symptoms before and after treatment. The Cunningham Panel aids a clinician’s treatment decision by directing them to the underlying subclinical infections and neuroimmune dysfunction, rather than simply treating symptoms. Effective treatments typically include various anti-infectives, anti-inflammatory agents and immunomodulators. Moleculera' s Test Panel generates an average realized revenue of $900 through existing CPT codes and patient billing. The Company has generated over $10 million in cumulative revenue since opening. During the COVID-19 pandemic, revenues for 2021 were $1.1 million, all prior to adding a sales force. Approximately 10% of orders come from a growing international market, with the Company receiving orders from over 1,700 clinicians. Moleculera Labs has one of the largest IRB approved and clinically annotated serum specimen biobanks of over 13,000 specimens utilized for research and development of new products for autoimmune neuropsychiatric disorders. The Company has demonstrated its panel’s clinical utility in multiple neuropsychiatric disorders and have been able to predict treatment efficacy while working with pharmaceutical and research partners to assist in identifying novel drug targets. There is a clear unmet medical need and demand in this $23 billion dollar neuropsychiatric and behavioral disorder market. Moleculera recently in-licensed exclusive technology for multiple autoimmune antibody targets against the heart, which are implicated in a portion of multiple cardiovascular diseases such as heart failure, cardiomyopathy, atrial fibrillation, and myocarditis. With this technology along with proposed clinical studies and validation in process, the Company expects to develop and commercialize two additional panels. One panel will target various cardiovascular diseases (world-wide market of $4.9 trillion) infection-triggered autoimmunity, and another panel for diagnosing and treatment-monitoring of Long-COVID (estimated at $6.5 trillion). Our precision medicine business model is fashioned after Foundation Medicine and Genomic Health, whose precision medicine companies were acquired by Roche in 2018 for $5.3 billion, and Exact Sciences in 2019 for $2.8 billion, respectively. Moleculera Labs is led by Dr. Craig Shimasaki, a serial entrepreneur with over 35 years of biotechnology experience, who began his career at Genentech. He co-founded multiple companies, participated in taking several companies public into the U.S. and the Canadian stock exchange, led five products through the FDA diagnostic approval process, and has directed two CLIA labs, raising over $30 million for these companies. Dr. Madeleine Cunningham, Chief Scientific Officer, is an internationally recognized leader in infection-induced autoimmune neuropsychiatric disorders and is a tenured professor at the University of Oklahoma with over 40 years of research and over 130 authored publications in leading scientific and medical journals. Dr. James Appleman is VP of R&D and Clinical Development and has 30+ years’ experience in building successful diagnostic and therapeutic companies from inception through successful exits, including a $230M exit to Roche. Mr. Fred Hiller is CFO and brings 45+ years’ experience in corporate finance and accounting. He began his career at Touche Ross & Co. in 1962, serving as controller at Elgin National and Columbia Pictures, and CFO at Wilkinson Sword. He has been a financial consultant to numerous companies including two biotechnology companies and one that was publicly traded.
Associated Material Processing
Convertible Note in 2015
Associated Material Processing, LLC is a manufacturer based in Stillwater, Oklahoma, specializing in chemical removal polymeric adsorbents for water purification. Founded in 2011, the company produces proprietary products such as ERAsE 35, a granular mesh adsorbent suitable for cleaning drinking water, groundwater, wastewater, and industrial treatments, and ERAsE 50, a free-flowing powder designed for filtration applications. The company addresses the critical issue of arsenic contamination, particularly in semiconductor manufacturing and processed foods, by offering low-cost media that effectively removes hazardous chemicals from various waste streams. This innovative approach enables manufacturers to provide purified water, contributing to the growing need for effective water treatment solutions worldwide.
Valve Systems International
Seed Round in 2015
Valve Systems International specializes in the development of advanced control valves, particularly engineered to manage fluid flow between high-pressure sources and low-pressure discharge volumes. The company's innovative internal mechanical actuation system enhances the reliability of fluid regulation while significantly lowering operating costs by minimizing maintenance and repair needs. Its proprietary technology also allows for precise modulation of fluid processes under choked flow conditions, offering substantial improvements in accuracy. This capability helps industries reduce internal damage caused by cavitation and vibration, positioning Valve Systems International as a key player in the severe service control valve market.
WeGoLook, LLC is a mobile technology company that provides on-demand inspection, verification, and field services through a crowdsourced platform of over 30,000 independent contractors, known as "Lookers." Headquartered in Oklahoma City, Oklahoma, WeGoLook serves both businesses and consumers in the United States and internationally, including markets such as the United Kingdom, Canada, and Australia. The company specializes in verifying various assets, including automobiles, motorcycles, RVs, and properties, and offers services such as accident scene inspections, document retrieval, indoor and outdoor asset verification, and custom tasking like item pickup and delivery. Clients engage with WeGoLook to obtain comprehensive inspection reports, which are compiled from field data, photos, and videos collected by Lookers using the WeGoLook mobile app. Following a quality assurance review, the reports are delivered to clients, including insurance providers, in various formats. WeGoLook aims to facilitate faster and more accurate verification processes for its clients while supporting a wide range of industries, from automotive to real estate and beyond. The company was founded in 2009 and operates as a subsidiary of Crawford & Company.
Synereca Pharmaceuticals
Debt Financing in 2014
Synereca Pharmaceuticals, Inc. is a research-stage biopharmaceutical company focused on developing orally active drugs that enhance the effectiveness of existing antibiotics. Founded in 2009, the company is headquartered in Chapel Hill, North Carolina, with additional laboratories in Oklahoma. Synereca's research centers on compounds that increase the activity of Colistin against gram-negative bacteria while avoiding toxicity. Its portfolio includes prototypic RecA inhibitors aimed at treating various pathogenic bacteria, including E. coli, which are responsible for infections in the lungs, urinary tract, and skin, as well as other harmful pathogens. The company identifies multiple chemical subclasses of compounds that potentiate various classes of antibiotics, including polymyxins, carbapenems, aminoglycosides, and fluoroquinolones, thereby facilitating the development of more effective treatments for bacterial infections.
Roll-2-Roll Technologies
Seed Round in 2014
Roll-2-Roll Technologies LLC is a start-up based in Stillwater, Oklahoma, that specializes in the development of electro-mechanical devices for roll-to-roll manufacturing applications. Incorporated in 2013, the company originated as a spin-off from Oklahoma State University and focuses on creating a lateral guide system that employs advanced sensor technology and algorithms. This innovative device aims to enhance manufacturing efficiency by minimizing downtime and reducing material waste. Roll-2-Roll Technologies offers a comprehensive range of products, including sensors, controllers, actuators, and other devices designed to improve web guiding and inspection processes, facilitating the easy integration of new technologies for manufacturers.
Well Checked Systems International
Seed Round in 2014
Well Checked Systems International, LLC, known as WellChecked, specializes in remote monitoring and reporting services for oil and gas well sites. Established in 2012 and headquartered in Tulsa, Oklahoma, the company provides a comprehensive unified monitoring platform that enhances the safety, security, and efficiency of well site operations. Its offerings include motion sensing, gate activity monitoring, tank level alerts, and cloud-based video surveillance with data storage and retrieval capabilities. The platform allows users to define guard patrols and monitor equipment power and motor proximity remotely. By leveraging advanced internet-based software, WellChecked helps clients reduce monitoring costs and personnel needs while minimizing the risk of equipment damage and loss.
Monscierge
Seed Round in 2014
Monscierge, LLC is an international software company based in Oklahoma City, Oklahoma, that specializes in innovative solutions for the hospitality industry. Founded in 2009, the company developed the Connect platform, which facilitates communication between hotel staff and guests through various devices, including mobile phones, tablets, large-screen kiosks, and web-based tools. Connect offers a range of features, including the ability for guests to order room service, make requests, access local recommendations, and manage reservations. The platform also includes tools for real-time communication among staff and a touch-interactive lobby solution for guests without personal devices. Monscierge's technologies are designed to enhance guest experiences and improve operational efficiency for hotels and hospitality brands worldwide, thereby fostering customer loyalty.
Otologic Pharmaceutics
Series A in 2014
Otologic Pharmaceutics, Inc. is a development-stage biopharmaceutical company based in Oklahoma City, Oklahoma, focused on creating innovative pharmacological solutions to address hearing disorders. Founded in 2009, the company is dedicated to developing treatments for acute hearing loss, particularly through its lead product, HPN1010, an oral medication designed to treat acute noise-induced hearing loss. Otologic Pharmaceutics aims to reduce the risk of permanent hearing disorders and has plans to expand the applications of HPN1010 to other forms of hearing loss, such as those induced by Cisplatin. In addition to HPN1010, the company is exploring a range of therapeutic programs targeting various hearing impairments, including secondary indications for Meniere's Disease and tinnitus, as well as preclinical efforts aimed at restoring hearing function in cases of chronic and age-related hearing loss.
Smart Panel
Seed Round in 2014
Smart Panel is focused on developing an innovative home energy management system designed to be mounted on the circuit breaker of residential and small commercial buildings. Unlike competing technologies that manage power at individual switches and plugs, Smart Panel offers a comprehensive solution by controlling energy distribution directly at the breaker, the central hub for electrical management. This approach allows homeowners to effectively monitor and manage their energy usage through a single, cost-effective device. Equipped with digital relays connected to each circuit, the intelligent electrical panel enables users to track real-time energy consumption and remotely turn off entire circuits using a smartphone, providing both convenience and enhanced energy efficiency.
Miira Artist Tools specializes in developing innovative art tools aimed at enhancing the artistic capabilities of professionals and beginners alike. The company offers modern solutions that facilitate the creation, learning, and teaching of fundamental artistic principles. By addressing common challenges such as the depiction of space, depth, distance, and linear perspective, Miira provides valuable resources for artists, art instructors, designers, and architects. Their tools are designed to make the artistic process more convenient and efficient, ultimately helping users to improve their skills and express their creativity more effectively.
ZarthCode
Seed Round in 2014
ZarthCode is a company focused on developing innovative virtual reality hardware, specifically consumer-level wireless virtual-reality gloves. The company excels in product design, prototyping, and manufacturing, aiming to deliver affordable and accessible virtual reality solutions. Its flagship product, the Mantis VR glove, represents a significant advancement in VR technology, offering users an immersive experience for various applications. By prioritizing both functionality and affordability, ZarthCode seeks to cater to a diverse range of consumer needs in the rapidly evolving VR market.
EQUIP Advantage
Seed Round in 2014
EQUIP Advantage provides immediate access to the oil and gas industry’s equipment at the right time.
SIVI's core product is LaunchLeader, the micro-crowdfunding platform for entrepreneurs to rally supporters and raise startup money for their prototypes (MVPs). The unique fundraising design is set up like a wedding registry wish list so donors can back specific startup tools, e.g. video, logo, social media ads. LaunchLeader is positioned as a pre-Kickstarter/Indiegogo or pre-accelerator crowdfunding platform when friends and family are your main supporters. LaunchLeader's parent company, SIVI, is a virtual incubator started by successful founders dedicated to democratizing entrepreneurship.
Tetherex Pharmaceuticals
Seed Round in 2014
Tetherex Pharmaceuticals, established in 2014 with headquarters in Oklahoma City, Oklahoma, is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics targeting inflammation, thrombosis, and tumor metastasis. The company's primary focus is on SelK2, a humanized monoclonal antibody designed to address these severe diseases. Tetherex operates within the healthcare industry, specifically in the biotechnology sector, with an additional office in Morrisville, North Carolina.
4DSales
Seed Round in 2014
4DSales is a company based in Tulsa, Oklahoma, that specializes in developing a tablet-based mobile sales application designed for sales professionals. This application enables users to effectively showcase products through live action videos, photos, and PDFs of specifications, facilitating customer engagement. The platform is characterized by its speed and ease of organization, providing sales teams with quick access to all necessary sales content. By enhancing the overall sales performance and responsiveness during sales calls, 4DSales aims to help businesses increase their revenue and improve their sales processes.
Tailwind
Seed Round in 2013
Tailwind is a prominent marketing platform tailored for small businesses, entrepreneurs, creators, and marketers. It provides tools that facilitate the planning, creation, execution, and optimization of marketing campaigns across various digital platforms, including email, Facebook, Instagram, and Pinterest. By integrating multiple standalone marketing tools into a unified system, Tailwind aims to empower small businesses to become effective omni-channel marketers, catering to their specific needs. Additionally, Tailwind offers a utility-first CSS framework designed to simplify content marketing, enabling users to enhance their marketing efforts and connect with a broader audience. Through its comprehensive suite of services, Tailwind is reshaping the marketing landscape for small businesses.
Moleculera Biosciences
Seed Round in 2013
Moleculera Labs was founded by Drs. Craig Shimasaki and Madeleine Cunningham in 2011, to medically understand and clinically identify the underlying biological root of neurological, psychiatric, and behavioral disorders. Similar to the emergence of the immuno-oncology connection, epidemiological and research evidence demonstrates that a large portion of neuropsychiatric disorders are caused by an autoimmune dysfunction. The Company owns and operates a fully accredited clinical laboratory with its first revenue generating product—a blood panel called the Cunningham Panel™ that detects brain and nervous system targeted autoimmune antibodies in patients with neurologic, psychiatric, and behavioral disorders triggered by an infection. Patients are diagnosed with PANS, PANDAS, autism spectrum disorder, ADD/ADHD, bipolar disorder, anxiety disorder, Tourette’s, obsessive compulsive disorder (OCD), schizophrenia, or other neurologic and psychiatric syndromes, whereas the root may be a dysfunctional immune response. Symptoms include OCD, anxiety, depression, psychosis, motor or vocal tics, verbal and non-verbal communication difficulty, deteriorating social skills, eating disorders, academic regression, and rage. These patients are typically prescribed neuropsychiatric drugs, often resulting in little or no improvement. However, once a patient is correctly diagnosed through testing, treatment is redirected towards the immune system, neuroinflammation, and subclinical infections, resulting in remarkable recoveries, sometimes after decades of suffering. Moleculera is the sole clinical laboratory performing this panel covered by two U.S. patents. The Company has received and processed over 13,000 blood specimens ordered by over 1,700 physicians in over 50 countries, all prior to launching a sales force. The Company generated $1.1 MM in 2021 and is preparing to scale for revenue expansion with expectations of revenue ~$25 MM in 4-5 years. The company is now applying this technology to autoimmune cardiovascular disease and Long-COVID symptoms. The basic research that led to the identification of these antineuronal antibody targets was studied for over 20 years in the laboratory of Dr. Madeleine Cunningham at The University of Oklahoma Health Sciences Center, with subsequent collaboration from the Pediatric Branch of the National Institutes of Mental Health (NIMH). Scientific and clinical results have been published in multiple top-tier peer-reviewed journals. Certain infections that have been found to trigger these autoimmune antibodies include strep, Lyme, mycoplasma, Babesia, bartonella, coxsackie virus, and others. Medical journals have reported an autoimmune response to SARS-CoV-2 (COVID-19), with approximately one-third of patients experiencing some neurologic or psychiatric symptoms. The patented Cunningham Panel™ consists of five tests. Four which measure levels of autoantibodies directed against Dopamine D1 receptor, Dopamine D2L receptor, Lysoganglioside GM1, and Tubulin. A fifth test measures CaM Kinase II activation, a key enzyme involved in the production of neurotransmitters dopamine, epinephrine, and norepinephrine. Autoimmune antibodies that bind to these targets interfere with or block normal neurologic activity in the brain and nervous system. The laboratory results assist a physician in making a diagnosis and identifying the appropriate therapy. In addition to individual clinicians who order the panel, the Company has provided testing to over 80 medical institution customers. In a 2020 publication in the Journal of Neuroimmunology, the Cunningham Panel demonstrated an 88% sensitivity and 92% specificity with an accuracy of 90% correlating these autoantibody elevations and neuropsychiatric symptoms before and after treatment. The Cunningham Panel aids a clinician’s treatment decision by directing them to the underlying subclinical infections and neuroimmune dysfunction, rather than simply treating symptoms. Effective treatments typically include various anti-infectives, anti-inflammatory agents and immunomodulators. Moleculera' s Test Panel generates an average realized revenue of $900 through existing CPT codes and patient billing. The Company has generated over $10 million in cumulative revenue since opening. During the COVID-19 pandemic, revenues for 2021 were $1.1 million, all prior to adding a sales force. Approximately 10% of orders come from a growing international market, with the Company receiving orders from over 1,700 clinicians. Moleculera Labs has one of the largest IRB approved and clinically annotated serum specimen biobanks of over 13,000 specimens utilized for research and development of new products for autoimmune neuropsychiatric disorders. The Company has demonstrated its panel’s clinical utility in multiple neuropsychiatric disorders and have been able to predict treatment efficacy while working with pharmaceutical and research partners to assist in identifying novel drug targets. There is a clear unmet medical need and demand in this $23 billion dollar neuropsychiatric and behavioral disorder market. Moleculera recently in-licensed exclusive technology for multiple autoimmune antibody targets against the heart, which are implicated in a portion of multiple cardiovascular diseases such as heart failure, cardiomyopathy, atrial fibrillation, and myocarditis. With this technology along with proposed clinical studies and validation in process, the Company expects to develop and commercialize two additional panels. One panel will target various cardiovascular diseases (world-wide market of $4.9 trillion) infection-triggered autoimmunity, and another panel for diagnosing and treatment-monitoring of Long-COVID (estimated at $6.5 trillion). Our precision medicine business model is fashioned after Foundation Medicine and Genomic Health, whose precision medicine companies were acquired by Roche in 2018 for $5.3 billion, and Exact Sciences in 2019 for $2.8 billion, respectively. Moleculera Labs is led by Dr. Craig Shimasaki, a serial entrepreneur with over 35 years of biotechnology experience, who began his career at Genentech. He co-founded multiple companies, participated in taking several companies public into the U.S. and the Canadian stock exchange, led five products through the FDA diagnostic approval process, and has directed two CLIA labs, raising over $30 million for these companies. Dr. Madeleine Cunningham, Chief Scientific Officer, is an internationally recognized leader in infection-induced autoimmune neuropsychiatric disorders and is a tenured professor at the University of Oklahoma with over 40 years of research and over 130 authored publications in leading scientific and medical journals. Dr. James Appleman is VP of R&D and Clinical Development and has 30+ years’ experience in building successful diagnostic and therapeutic companies from inception through successful exits, including a $230M exit to Roche. Mr. Fred Hiller is CFO and brings 45+ years’ experience in corporate finance and accounting. He began his career at Touche Ross & Co. in 1962, serving as controller at Elgin National and Columbia Pictures, and CFO at Wilkinson Sword. He has been a financial consultant to numerous companies including two biotechnology companies and one that was publicly traded.
Codesy operates an open-source marketplace that connects developers of software with individuals seeking to address valuable software bugs. Through a pay-what-you-want model, Codesy allows coders to engage in transactions, enabling them to set their own fees for their services. This platform facilitates interactions between computer programmers and buyers of apps and websites, streamlining the process of service engagement in the software development community. By promoting an open-source approach, Codesy fosters a collaborative environment where developers can leverage their skills while offering flexibility in pricing for their contributions.
Offerboxx
Seed Round in 2013
Offerboxx is a location based marketing software that makes it possible for businesses to collect rich information from consumers on-site and in an engaging way. Offerboxx makes that data available instantly and in a way that measures the results of each campaign.
Synercon Technologies
Seed Round in 2013
Synercon Technologies, LLC is a technology company based in Tulsa, Oklahoma, specializing in extracting digital data from heavy vehicles involved in crashes. Founded in 2013, it develops innovative solutions to retrieve data from a vehicle's engine control module (ECM) in a forensically sound manner. Its key products include the Forensic Link Adapter (FLA), which downloads data from heavy vehicles, and the Smart Sensor Simulator, which allows investigators to conduct bench downloads without causing additional fault codes. Additionally, Synercon offers TruckCRYPT, a software solution that encrypts and presents extracted data to users. The company provides a range of services, including chip-level digital forensics, field data extraction, crash reconstruction, expert testimony, and electronics design. By employing a custom hardware and software approach, Synercon enhances the efficiency and reliability of forensic investigations in the heavy vehicle sector.
Tempered Mind
Seed Round in 2013
Tempered Mind is a mobile-first educational technology company that combines engaging game formats with proven teaching methods. Their primary product, Call to Knowledge: FLV, focuses on language learning, helping users expand their vocabulary in multiple languages through interactive, fun exercises accessible via mobile devices.
Drik is a laboratory testing facility located in Oklahoma City that specializes in toxicology services for pharmaceutical companies developing new drugs. Founded and led by Kumar Sripathirathan, Drik offers customized testing solutions that assist researchers in determining toxicology requirements and evaluating the safety of their drug candidates. The company conducts a variety of pre-clinical screening tests, in vitro testing, and animal studies, alongside in vivo toxicology assessments and cell-based assays that investigate disease mechanisms. Through its comprehensive testing capabilities, Drik enables pharmaceutical companies to effectively identify and address safety concerns associated with new drug development.
Sway Medical
Series A in 2013
Sway Medical, LLC is a developer of medical-grade mobile applications focused on monitoring patient outcomes in orthopedics, geriatrics, and pharmacology. Founded in 2011 and based in Aledo, Texas, the company offers the Sway Balance software, which utilizes patent-pending motion analysis protocols to assess balance and detect instability, particularly after head injuries. This innovative application provides healthcare professionals with objective data for evaluating musculoskeletal, neurological, and vestibular dysfunction, facilitating effective concussion management and balance testing. Sway Medical's solutions are applicable in various settings, including physical therapy practices, senior living facilities, and worksite medical clinics, allowing for real-time monitoring of patient performance and health status.
ICEdot, a Tulsa, Oklahoma-based developer of a crash sensor attached to the safety helmet of sportsmen. Led by Chris Zenthoefer, CEO, ICEdot has developed a crash sensor attached to the safety helmet of cyclists, skiers, snow boarders, BMX bikers and other action sport participants to detect forces consistent with head injury and notify predesignated health and geolocation information over sms/text.
Retenant
Seed Round in 2013
Retenant specializes in developing custom mobile applications tailored for apartment complexes, enhancing communication between property managers and residents. By replacing traditional methods like paper fliers, portals, and emails with a dedicated app, Retenant facilitates more efficient and immediate interactions. This platform allows residents to report issues and provide feedback conveniently, enabling property managers to address problems swiftly and improve overall resident satisfaction. The company's focus is on building stronger communities within apartment complexes through better communication and service delivery.
The Campaign Solution
Seed Round in 2013
The Campaign Solution optimizes candidates’ time and resources. It was founded by Dan Mazzei in 2010.
EmpowrNet
Seed Round in 2013
EmpowrNet will offer a mobile application that supports consumers, their family members and their friends in their collective effort to manage the array of long term care services and supports required to safely live at home and avoid nursing home care. Nine of ten individuals age 50+ want to age in place - to live at home as independently as possible as long as possible and avoid nursing home placement. For both consumers and family members the primary concern related to supporting aging in place is retaining the control over their lives they had before the need for long term care services entered the picture. EmpolwrNet's communication tool will give consumers and their families the opportunity to retain control of their lives by gives them the tools to successfully manage the challenges of aging in place.
Medefy is a healthcare application established in 2018 and based in Tulsa, Oklahoma. It provides a platform that enables employers to engage effectively with their employees regarding health benefits. By facilitating direct communication, Medefy empowers employees to make informed healthcare decisions and shop for affordable, high-quality healthcare providers in their vicinity. The platform offers comprehensive support throughout the healthcare journey, combining one-on-one navigation assistance with digital health tools such as telemedicine and chronic disease management. This integrated experience helps employees navigate the complexities of healthcare benefits, ultimately leading to more cost-effective care solutions.
Polyskope Labs
Seed Round in 2013
Polyskope Labs specializes in the development of clinical molecular diagnostics, focusing on innovative solutions for food safety testing. The company has pioneered a comprehensive, modular multiplex assay that enables the simultaneous detection of one to three common foodborne pathogens. This groundbreaking technology significantly reduces the cost of analysis for food safety laboratories, achieving more than a threefold decrease in expenses. By utilizing a single overnight enrichment medium, Polyskope's assay streamlines the detection process, minimizing the need for multiple materials, labor, and equipment, while also decreasing logistical challenges and regulatory burdens. Through these advancements, Polyskope Labs aims to enhance the efficiency and effectiveness of food safety testing.
Docvia is a privately held software venture that provides secure, HIPAA-compliant electronic access between established patients and their health providers. The company's software was first commercially deployed at St. John Health System in Tulsa, Oklahoma. The Docvia team is comprised of practicing physicians, software engineers and designers that work together with community leaders in order to provide safe, simple and inexpensive health access around the world.
Expert TA
Venture Round in 2012
Expert TA, LLC is a company that specializes in providing web-based software for partial-credit grading, specifically designed for use by professors and teaching assistants in higher education. Established in 2009 and based in Tulsa, Oklahoma, the company focuses on enhancing the educational experience by simplifying the grading process for homework in disciplines such as engineering, mathematics, physics, and chemistry. Its offerings include Homework Mode, which enables educators to create assignments and export grade information for integration with other software, and Tutorial Mode, which provides guidance akin to office hours tutoring sessions. By automating the grading of complex problems, Expert TA allows educators to devote more time to teaching and student engagement, thereby improving overall learning outcomes.
Perk Dynamics
Venture Round in 2012
Perk Dynamics, Inc. is a software development company that specializes in providing operational management solutions for the hospitality and specialty coffee industry. Founded in 2009 and based in Shawnee, Oklahoma, the company focuses on enhancing the efficiency and quality of beverage order processes. Its flagship product, AutoPerk, serves as an automated interface connecting point-of-sale systems to espresso and coffee machines, streamlining the order entry process. Additionally, Perk Dynamics offers AutoPerk SelfCheck, a self-service solution for delivering freshly brewed beverages, and PerkAlert, which allows remote management of coffee operations across multiple locations. The company caters to a diverse clientele, including franchisors, roasters, maintenance providers, and restaurant operators, across various sectors such as grocery stores, casinos, hotels, and coffee cafés.
DermaMedics
Venture Round in 2012
DermaMedics LLC is a pharmaceutical skin care company based in Oklahoma City, Oklahoma, that focuses on developing innovative topical therapeutics for the dermatology market. Founded in 2010, the company specializes in creating skin care products for medical professionals, including anti-aging treatments and relief products for various skin conditions such as psoriasis, acne, rosacea, and eczema. One of its key advancements is Therosol®, a unique phytochemical compound derived from natural sources like basil and nutmeg, known for its anti-inflammatory and anti-aging properties. Clinical research has demonstrated the efficacy of Therosol® in treating inflammatory skin issues and preventing radiation burns in cancer patients. DermaMedics markets its extensive range of products—including moisturizers, cleansers, serums, and creams—through retailers, aiming to provide safe and effective solutions that enhance skin health without the adverse effects associated with traditional corticosteroids and immunosuppressive treatments.
Oklahoma Medical Research Foundation
Seed Round in 2012
The Oklahoma Medical Research Foundation (OMRF) is a non-profit biomedical research institute dedicated to understanding and treating various devastating illnesses, including Alzheimer's, heart disease, lupus, multiple sclerosis, and cancer. It operates a research facility, providing services and access to resources that facilitate drug discoveries and improve patient care.
Alkami
Convertible Note in 2009
Alkami Technology, Inc. is a provider of cloud-based digital banking solutions tailored for credit unions and banks. The company offers the ORB Platform, a comprehensive Software-as-a-Service solution that facilitates retail and business banking features including account aggregation, person-to-person payments, payroll management, and analytics. Alkami's platform enhances user onboarding, engagement, and account servicing, allowing financial institutions to improve operational efficiency and drive revenue growth. Additionally, it includes integrated mobile banking solutions, a content management system for personalized marketing, and the flexibility to incorporate third-party solutions. Founded in 2007 and headquartered in Plano, Texas, Alkami was previously known as iThryv, LLC before rebranding in 2010.
Grocio, Inc. is a grocery comparison shopping platform based in Tulsa, Oklahoma, established in 2007. The company offers a range of services designed to assist both shoppers and grocers, including local grocery price comparisons, real-time pricing data, and coupon matching to grocery lists. Additionally, Grocio provides mobile tools that enhance the shopping experience, making it easier for users to find the best deals and manage their grocery purchases effectively. Through its innovative approach, Grocio aims to streamline the grocery shopping process and help consumers make informed choices.
Exerbotics
Seed Round in 2009
Exerbotics, LLC is a manufacturer of advanced fitness and wellness equipment based in Tulsa, Oklahoma, founded in 2004. The company specializes in designing technology-driven devices tailored for medical, rehabilitation, senior living, and commercial fitness applications. Their product range includes machines for various muscle groups, such as chest press, shoulder press, leg press, and more, all of which are equipped to measure and record force output. This data facilitates future analysis, diagnosis, and training prescriptions. Exerbotics also provides solutions for analyzing, repairing, and backing up performance data, along with detailed reports on biometrics and workout history. By leveraging technology, Exerbotics aims to enhance healthy living and improve quality of life through its innovative fitness solutions.
Selexys Pharmaceuticals Corporation
Seed Round in 2009
Selexys Pharmaceuticals Corporation (Selexys) is a privately held company that is developing drugs to treat inflammatory and thrombotic diseases. They are targeting the underlying disease mechanism for these disorders. Their target is the adhesion of white blood cells to sites of inflammation mediated by the binding of two proteins, P-selectin and PSGL-1. The company is in preclinical development of humanized antibodies to P-selectin and PSGL-1 for the treatment of acute and chronic inflammatory and thrombotic disorders. Unregulated inflammatory processes play a major role in the harmful effects of multiple inflammatory disorders.
mobiManage
Angel Round in 2008
mobiManage is a prominent provider of mobile web solutions aimed at enhancing digital brand identity for businesses. The company specializes in creating adaptive mobile technologies that seamlessly integrate with existing websites, content management systems, customer relationship management systems, and databases. By focusing on custom mobile websites and applications, mobiManage delivers engaging mobile products that are compatible across various platforms, including iOS and Android. With a portfolio of over 400 custom designs, the company equips clients with the necessary tools to implement effective mobile marketing strategies. Their mobiPlatform allows for the deployment, management, and real-time support of mobile products, incorporating features such as mobile advertising, surveys, and geolocation services. Additionally, mobiManage offers responsive server-side website design and kiosk solutions, ensuring a comprehensive approach to mobile marketing. They provide free estimates and proposals, making their services accessible to businesses seeking to enhance their mobile presence.
CreditPoint Software
Seed Round in 2008
CreditPoint Software, Inc. is a company that specializes in developing software solutions for commercial credit risk and collections management. Founded in 2000 and headquartered in Tulsa, Oklahoma, the firm offers a comprehensive SaaS platform designed to assist businesses of all sizes, from small and medium enterprises to Fortune 500 companies. Its software suite includes features such as online credit applications, configurable scoring models, analytics-driven monitoring, and business intelligence reporting. By enabling effective credit risk management and collection processes, CreditPoint Software aims to enhance operational efficiency, reduce errors, and provide critical insights that help businesses mitigate risk and optimize cash flow.
Lifetone Technology
Seed Round in 2008
Lifetone Technology, Inc. is a manufacturer of bedside fire alarm and clock products designed to enhance safety for children, seniors, heavy sleepers, and individuals who are deaf or hard of hearing. The company’s flagship brand, Lifetone HL, includes innovative devices such as a bedside fire alarm that integrates a bed shaker, which emits strong vibrations to alert users in case of a fire. Founded in 2004 and based in Oklahoma City, Oklahoma, Lifetone Technology also operates additional offices in Chicago. The company markets its lifesaving products online and through various dealers across the United States. Originally established as InnovAlarm Corporation, it rebranded to Lifetone Technology in January 2008.